AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
Log in

NASDAQ:ALGNAlign Technology Stock Price, Forecast & News

$270.24
-3.05 (-1.12 %)
(As of 07/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$269.45
Now: $270.24
$279.46
50-Day Range
$238.28
MA: $264.83
$289.75
52-Week Range
$127.88
Now: $270.24
$301.65
Volume647,597 shs
Average Volume1.11 million shs
Market Capitalization$21.28 billion
P/E Ratio11.33
Dividend YieldN/A
Beta2.01
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontics, and restorative and aesthetic dentistry worldwide. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign Comprehensive treatment that addresses the orthodontic needs of teenage patients, such as compliance indicators and compensation for tooth eruption; Invisalign Assist treatment, which offers support to dental practitioners throughout the treatment process, including progress tracking; and Invisalign First Phase I and Invisalign First Comprehensive Phase II package for younger patients with early mixed dentition with a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign Express 10, Invisalign Express 5, Express Package, Lite Package, Invisalign Go, and SmileDirectClub; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers; computer-aided design/computer-aided manufacturing services and ancillary products, such as disposable sleeves for the wand; and iTero applications and tools. The company was founded in 1997 and is headquartered in San Jose, California.
Read More
Align Technology logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 3.1 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.85 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ALGN
CUSIP01625510
Phone408-470-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.41 billion
Cash Flow$5.97 per share
Book Value$17.08 per share

Profitability

Net Income$442.78 million

Miscellaneous

Employees14,530
Market Cap$21.28 billion
Next Earnings Date7/22/2020 (Confirmed)
OptionableOptionable

Receive ALGN News and Ratings via Email

Sign-up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter.

Align Technology (NASDAQ:ALGN) Frequently Asked Questions

How has Align Technology's stock been impacted by COVID-19 (Coronavirus)?

Align Technology's stock was trading at $202.18 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ALGN stock has increased by 33.7% and is now trading at $270.24. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Align Technology?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Align Technology.

When is Align Technology's next earnings date?

Align Technology is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for Align Technology.

How can I listen to Align Technology's earnings call?

Align Technology will be holding an earnings conference call on Wednesday, July 22nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Align Technology's earnings last quarter?

Align Technology, Inc. (NASDAQ:ALGN) released its earnings results on Wednesday, April, 29th. The medical equipment provider reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.00 by $0.27. The medical equipment provider had revenue of $551 million for the quarter, compared to the consensus estimate of $557.54 million. Align Technology had a net margin of 78.42% and a return on equity of 107.18%. The firm's quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.89 earnings per share. View Align Technology's earnings history.

What price target have analysts set for ALGN?

13 equities research analysts have issued 12-month target prices for Align Technology's shares. Their forecasts range from $165.00 to $360.00. On average, they anticipate Align Technology's share price to reach $254.82 in the next twelve months. This suggests that the stock has a possible downside of 5.7%. View analysts' price targets for Align Technology.

Has Align Technology been receiving favorable news coverage?

News articles about ALGN stock have been trending very negative on Monday, InfoTrie Sentiment reports. The research firm rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Align Technology earned a media sentiment score of -3.2 on InfoTrie's scale. They also gave news stories about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about Align Technology.

Are investors shorting Align Technology?

Align Technology saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 3,810,000 shares, a drop of 21.1% from the June 15th total of 4,830,000 shares. Based on an average trading volume of 1,220,000 shares, the short-interest ratio is currently 3.1 days. Currently, 5.3% of the shares of the stock are sold short. View Align Technology's Current Options Chain.

Who are some of Align Technology's key competitors?

What other stocks do shareholders of Align Technology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Alibaba Group (BABA), Netflix (NFLX), Paypal (PYPL), Micron Technology (MU), Adobe (ADBE), Visa (V), salesforce.com (CRM), Mastercard (MA) and Boeing (BA).

Who are Align Technology's key executives?

Align Technology's management team includes the following people:
  • Mr. Joseph M. Hogan, Pres, CEO & Director (Age 62)
  • Mr. John F. Morici, CFO & Sr. VP of Global Fin. (Age 52)
  • Mr. Stuart Hockridge, Sr. VP of Global HR (Age 47)
  • Mr. Raphael S. Pascaud, Sr. VP of Bus. Devel. & Strategy (Age 47)
  • Mr. Emory M. Wright, Sr. VP of Global Operations (Age 49)

What is Align Technology's stock symbol?

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Who are Align Technology's major shareholders?

Align Technology's stock is owned by a number of retail and institutional investors. Top institutional investors include Riverbridge Partners LLC (0.15%), Envestnet Asset Management Inc. (0.12%), West Coast Financial LLC (0.04%), State of Alaska Department of Revenue (0.03%), DNB Asset Management AS (0.02%) and IFM Investors Pty Ltd (0.01%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, Greg J Santora, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Simon Beard, Sreelakshmi Kolli, Stuart A Hockridge, Susan E Siegel, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler and Yuval Shaked. View institutional ownership trends for Align Technology.

Which major investors are selling Align Technology stock?

ALGN stock was sold by a variety of institutional investors in the last quarter, including West Coast Financial LLC, Envestnet Asset Management Inc., IFM Investors Pty Ltd, Global Retirement Partners LLC, and Diversified Trust Co. Company insiders that have sold Align Technology company stock in the last year include Andrea Lynn Saia, John Morici, Joseph Lacob, Julie Tay, Stuart A Hockridge, Susan E Siegel, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler, and Yuval Shaked. View insider buying and selling activity for Align Technology.

Which major investors are buying Align Technology stock?

ALGN stock was acquired by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, State of Alaska Department of Revenue, Canandaigua National Corp, Contravisory Investment Management Inc., Cypress Capital Group, Ipswich Investment Management Co. Inc., DNB Asset Management AS, and Municipal Employees Retirement System of Michigan. Company insiders that have bought Align Technology stock in the last two years include Joseph M Hogan, and Vamsi Mohan Raj Pudipeddi. View insider buying and selling activity for Align Technology.

How do I buy shares of Align Technology?

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Align Technology's stock price today?

One share of ALGN stock can currently be purchased for approximately $270.24.

How big of a company is Align Technology?

Align Technology has a market capitalization of $21.28 billion and generates $2.41 billion in revenue each year. The medical equipment provider earns $442.78 million in net income (profit) each year or $4.96 on an earnings per share basis. Align Technology employs 14,530 workers across the globe.

What is Align Technology's official website?

The official website for Align Technology is www.aligntech.com.

How can I contact Align Technology?

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]

This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.